GlobalData on MSN15d
FDA approves drug application for Lupin’s heart failure therapy
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and Valsartan tablets for heart failure patients. Sacubitril and Valsartan ...
Drug firm Lupin gets USFDA nod for generic HIV medication
The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily single-pill regimen, indicated for the treatment of HIV-1 infection in ...
devdiscourse6d
Lupin Gains USFDA Nod for Generic HIV Drug Launch
Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...
Pharmabiz6d
Lupin receives US FDA tentative approval for generic Symtuza tablets
This ANDA has been found to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Symtuza tablets, 800 mg/150 mg/200 mg/10 mg of Janssen Products, LP. Lupin is the ...
Daily10d
Lupin's Generic Entresto Approved by USFDA, Set to Rival Novartis' Bestseller
Mumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received ...
Pharmabiz16d
Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection
Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...